California's Stem Cell Agency
California Institute for regenerative medicine
The State stem cell agency

Induced pluripotent stem cells (iPSC) and neurologic disease modeling: Progress and Promises.

Journal: 
Hum Mol Genet
Publication Year: 
2011
Authors: 
M C Marchetto
K J Brennand
L Boyer
F H Gage
PubMed link: 
Read the abstract
Funding Grants: 
Molecular and Cellular Transitions from ES Cells to Mature Functioning Human Neurons
Development of Induced Pluripotent Stem Cells for Modeling Human Disease
Training in the Biology of Human Embryonic Stem Cells and Emerging Technologies II
Public Summary: 
The systematic generation of neurons from patients with neurological disorders can provide important insights into disease pathology, progression and mechanism. This review will discuss recent progress in modeling neurodegenerative and neurodevelopmental diseases using induced pluripotent stem cells (iPSCs) and highlight some of the current challenges in the field. Combined with other technologies previously used to study brain disease, iPSC modeling has the promise to influence modern medicine on several fronts: early diagnosis, drug development and effective treatment.
Scientific Abstract: 
The systematic generation of neurons from patients with neurological disorders can provide important insights into disease pathology, progression and mechanism. This review will discuss recent progress in modeling neurodegenerative and neurodevelopmental diseases using induced pluripotent stem cells (iPSCs) and highlight some of the current challenges in the field. Combined with other technologies previously used to study brain disease, iPSC modeling has the promise to influence modern medicine on several fronts: early diagnosis, drug development and effective treatment.